EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acceptability and feasibility of chemoprophylaxis with single-dose rifampicin in four leprosy-endemic districts in Benin

Parfait Djossou iD, Zinsou Franck Maurille Mignanwande, Sèdjro Gimatal Esaï Anagonou iD, Irene Cerda, Alice Toussaint, Jean Gabin Houezo, Ghislain Emmanuel Sopoh, Anna Gine March, Roch Christian Johnson

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Parfait Djossou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre Interfacultaire de Formation et de Recherche en Environnement pour le Développement Durable, Université d'Abomey-Calavi, Cotonou, Bénin. Hauptthemen laut MEDLINE: Leprosy, Rifampin, Leprostatic Agents, Chemoprevention. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation Raoul Follereau, Fondation ANESVAD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds Chemoprophylaxis with single-dose rifampicin (SDR) is a preventive measure recommended by the World Health Organization to limit leprosy transmission. This study was carried out to assess the acceptability and feasibility of this measure in Benin.

Methods

This intervention-oriented study, including contacts of people affected by leprosy (PALs), was conducted in two linear phases from September 2019 to August 2020 in Benin. In the first phase, we assessed contacts’ knowledge of leprosy and their perceptions of SDR through interviews conducted after their informed consent. In the second phase, contacts were educated about leprosy and the importance of SDR in leprosy control. Eligible contacts were clinically examined, and new leprosy patients were treated with multidrug therapy while consented healthy contacts received the SDR.

Results

9,941 contacts were registered around 197 PALs. After interviewing 394 contacts, the majority (88.8%) had insufficient leprosy knowledge. Of these contacts, 58.6% agreed to receive chemoprophylaxis. They were willing to take the necessary time for treatment (74.5%), travel long distances (83.1%) and take the drug as often as possible (90.0%). Marital status (p = 0.008), education level (p = 0.000) and knowledge of leprosy (p = 0.000) were statistically linked to chemoprophylaxis acceptance. Contacts who lived alone, who weren’t educated and had little knowledge of leprosy were respectively 2.18, 2.75 and 43.13 times more likely to refuse chemoprophylaxis. Of the 9,941 sensitized contacts, 6,798 were clinically examined, and 6,416 received SDR. The average age of contacts who received chemoprophylaxis was 27.3 years (±19.8), with a predominance of women (52.7%). Eight (8) new patients were identified and treated with multidrug therapy.

Conclusion

It is important to increase awareness to improve knowledge of leprosy to contribute to chemoprophylaxis acceptance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyRifampinLeprostatic AgentsChemopreventionPatient Acceptance of Health CareHumansBeninFemaleMaleAdultMiddle AgedYoung AdultAdolescentFeasibility StudiesHealth Knowledge, Attitudes, PracticeAgedChildEndemic Diseases

Substanzen

RifampinLeprostatic Agents

Autor:innen und Institutionen

  • Centre Interfacultaire de Formation et de Recherche en Environnement pour le Développement Durable, Université d'Abomey-Calavi, Cotonou, Bénin.
  • Fondation Anesvad, Bilbao, Espagne.
  • Fondation Raoul Follereau, Paris, France.
  • Ministry of Health, Programme National de Lutte contre la Lèpre et l'Ulcère de Buruli, Cotonou, Bénin.
  • Institut Régional de Santé Publique de Ouidah, Université d'Abomey-Calavi, Cotonou, Bénin.

ORCID-Profile: Parfait Djossou, Sèdjro Gimatal Esaï Anagonou

Förderung

  • Fondation Raoul Follereau
  • Fondation ANESVAD

Zitieren

APA

Djossou, P., Mignanwande, Z. F. M., Anagonou, S. G. E., Cerda, I., Toussaint, A., Houezo, J. G., Sopoh, G. E., Gine March, A., & Johnson, R. C. (2025). Acceptability and feasibility of chemoprophylaxis with single-dose rifampicin in four leprosy-endemic districts in Benin. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013057

Vancouver

Djossou P, Mignanwande ZFM, Anagonou SGE, Cerda I, Toussaint A, Houezo JG, et al. Acceptability and feasibility of chemoprophylaxis with single-dose rifampicin in four leprosy-endemic districts in Benin. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013057

BibTeX
@article{Djossou2025,
  author = {Djossou, Parfait and Mignanwande, Zinsou Franck Maurille and Anagonou, Sèdjro Gimatal Esaï and Cerda, Irene and Toussaint, Alice and Houezo, Jean Gabin and Sopoh, Ghislain Emmanuel and Gine March, Anna and Johnson, Roch Christian},
  title = {Acceptability and feasibility of chemoprophylaxis with single-dose rifampicin in four leprosy-endemic districts in Benin},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013057}
}
Kostenlos starten →